PD-L(1) checkpoint inhibitor stakeholder meeting outcome statement

12 April 2019 - The outcome statement for the PD-(L)1 checkpoint inhibitor stakeholder meeting held on 8 February 2019 , ...

Read more →

Institute for Clinical and Economic Review posts draft scoping document for the assessment of treatments for rheumatoid arthritis

11 April 2019 - Document open to public comment until 1 May 2019. ...

Read more →

Institute for Clinical and Economic Review releases draft evidence report on treatments for peanut allergy

9 April 2019 - Public comment period now open until 8 May 2019; requests to make oral comment during public ...

Read more →

Drug Utilisation Sub-Committee outcome statement

29 March 2019 - The outcome statement from the February 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals)

15 March 2019 - The Public Summary Documents (first time rejections and deferrals) from the November 2018 PBAC meeting are now ...

Read more →

Institute for Clinical and Economic Review publishes white paper on alternative models for pharmaceutical rebates

12 March 2019 - Paper explores how reforming or eliminating rebates may affect drug pricing, patient access, and incentives for future ...

Read more →

Identifying the need for good practices in health technology assessment-summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

26 January 2019 - The systematic use of evidence to inform healthcare decisions, particularly health technology assessment, has gained increased recognition.  ...

Read more →

FDA is urged to mandate disclosure of clinical trial summaries as pilot program stalls

16 January 2019 - One year after the FDA launched a voluntary pilot program to release clinical study reports, which ...

Read more →

PBS Expenditure and Prescriptions Report 2017-18

11 January 2019 - The PBS Expenditure and Prescriptions Report 2017-18 is now available. ...

Read more →

CMS Office of the Actuary releases 2017 national health expenditures

6 December 2018 - Overall national health spending grew at a rate of 3.9% in 2017, almost 1.0 percentage point ...

Read more →

Canada's HTA agency releases report on international biosimilar policies

8 November 2018 - The Canadian Agency for Drugs and Technologies in Health (CADTH), the Canadian entity responsible for health ...

Read more →

Public Summary Documents - April 2018 PBAC meeting

9 November 2018 - The Public Summary Documents from the April 2018 PBAC meeting are now available. ...

Read more →

Public Summary Documents - July 2018 PBAC meeting

9 November 2018 - The second tranche of Public Summary Documents from the July 2018 PBAC meeting (first time rejections and ...

Read more →

Report on the collection of under co-payment data 2017-18

5 November 2018 - The report on the collection of under co-payment data 2017-18 is now available. ...

Read more →

Drug Utilisation Sub-Committee outcome statement - September 2018

2 November 2018 - The outcome statement from the September 2018 Drug Utilisation Sub Committee meeting is now available. ...

Read more →